HEALTH● LOWAug 26 · Aug 26, 2026, 11:09 PM
FDA approves new drug Rasonque to treat advanced pancreatic cancer
France 24 [en]
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHnowWHO supports Nigeria after first Ebola case confirmedUN NewsHEALTH36m agoNigeria confirms an Ebola case linked to East AfricaBBC AfriqueHEALTHBREAKING45m agoNigeria reports first Ebola case in a decadenorthweststar.com.au · AustraliaHEALTH1h agoBharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapyThe Hindu